Paolo Nuciforo
Paolo Nuciforo
Molecular Pathologist, VHIO
Email verificata su vhio.net
Titolo
Citata da
Citata da
Anno
Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication
R Di Micco, M Fumagalli, A Cicalese, S Piccinin, P Gasparini, C Luise, ...
Nature 444 (7119), 638-642, 2006
15782006
Mitf regulation of Dia1 controls melanoma proliferation and invasiveness
S Carreira, J Goodall, L Denat, M Rodriguez, P Nuciforo, KS Hoek, ...
Genes & development 20 (24), 3426-3439, 2006
4662006
NUMB controls p53 tumour suppressor activity
IN Colaluca, D Tosoni, P Nuciforo, F Senic-Matuglia, V Galimberti, G Viale, ...
Nature 451 (7174), 76-80, 2008
3762008
Molecular and immunohistochemical analysis of HER2/neu oncogene in synovial sarcoma
PG Nuciforo, C Pellegrini, R Fasani, M Maggioni, G Coggi, A Parafioriti, ...
Human Pathology 34 (7), 639-645, 2003
3092003
Tumor-infiltrating lymphocytes and associations with pathological complete response and event-free survival in HER2-positive early-stage breast cancer treated with lapatinib …
R Salgado, C Denkert, C Campbell, P Savas, P Nuciforo, C Aura, ...
JAMA oncology 1 (4), 448-455, 2015
2872015
Tip60 is a haplo-insufficient tumour suppressor required for an oncogene-induced DNA damage response
C Gorrini, M Squatrito, C Luise, N Syed, D Perna, L Wark, F Martinato, ...
Nature 448 (7157), 1063-1067, 2007
2872007
Analysis of Fusobacterium persistence and antibiotic response in colorectal cancer
S Bullman, CS Pedamallu, E Sicinska, TE Clancy, X Zhang, D Cai, ...
Science 358 (6369), 1443-1448, 2017
2682017
Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: a proof-of-principle
L De Mattos-Arruda, B Weigelt, J Cortes, HH Won, CKY Ng, P Nuciforo, ...
Annals of oncology 25 (9), 1729-1735, 2014
2482014
Genomic aberrations in the FGFR pathway: opportunities for targeted therapies in solid tumors
R Dienstmann, J Rodon, A Prat, J Perez-Garcia, B Adamo, E Felip, ...
Annals of oncology 25 (3), 552-563, 2014
2342014
PIK3CA mutations are associated with decreased benefit to neoadjuvant human epidermal growth factor receptor 2–targeted therapies in breast cancer
IJ Majewski, P Nuciforo, L Mittempergher, AJ Bosma, H Eidtmann, ...
Journal of clinical oncology 33 (12), 1334, 2015
1852015
Brn-2 represses microphthalmia-associated transcription factor expression and marks a distinct subpopulation of microphthalmia-associated transcription factor–negative melanoma …
J Goodall, S Carreira, L Denat, D Kobi, I Davidson, P Nuciforo, RA Sturm, ...
Cancer research 68 (19), 7788-7794, 2008
1622008
The prolyl-isomerase Pin1 is a Notch1 target that enhances Notch1 activation in cancer
A Rustighi, L Tiberi, A Soldano, M Napoli, P Nuciforo, A Rosato, F Kaplan, ...
Nature cell biology 11 (2), 133-142, 2009
1562009
Frequent alterations in the expression of serine/threonine kinases in human cancers
M Capra, PG Nuciforo, S Confalonieri, M Quarto, M Bianchi, M Nebuloni, ...
Cancer research 66 (16), 8147-8154, 2006
1362006
Breast cancer metastases are molecularly distinct from their primary tumors
M Vecchi, S Confalonieri, P Nuciforo, MA Vigano, M Capra, M Bianchi, ...
Oncogene 27 (15), 2148-2158, 2008
1312008
Assessing tumor infiltrating lymphocytes in solid tumors: a practical review for pathologists and proposal for a standardized method from the International Immuno-Oncology …
S Hendry, R Salgado, T Gevaert, PA Russell, T John, B Thapa, M Christie, ...
Advances in anatomic pathology 24 (6), 311, 2017
1282017
Survival prediction of stage I lung adenocarcinomas by expression of 10 genes
F Bianchi, P Nuciforo, M Vecchi, L Bernard, L Tizzoni, A Marchetti, ...
The Journal of clinical investigation 117 (11), 3436-3444, 2007
1252007
Alterations of ubiquitin ligases in human cancer and their association with the natural history of the tumor
S Confalonieri, M Quarto, G Goisis, P Nuciforo, M Donzelli, G Jodice, ...
Oncogene 28 (33), 2959-2968, 2009
1242009
HER2-enriched subtype as a predictor of pathological complete response following trastuzumab and lapatinib without chemotherapy in early-stage HER2-positive breast cancer …
A Llombart-Cussac, J Cortés, L Paré, P Galván, B Bermejo, N Martínez, ...
The lancet oncology 18 (4), 545-554, 2017
1202017
8p11 myeloproliferative syndrome with a novel t(7;8) translocation leading to fusion of the FGFR1 and TIF1 genes
E Belloni, M Trubia, P Gasparini, C Micucci, C Tapinassi, S Confalonieri, ...
Genes, Chromosomes and Cancer 42 (3), 320-325, 2005
1132005
Assessing tumor infiltrating lymphocytes in solid tumors: a practical review for pathologists and proposal for a standardized method from the International Immuno-Oncology …
S Hendry, R Salgado, T Gevaert, PA Russell, T John, B Thapa, M Christie, ...
Advances in anatomic pathology 24 (5), 235, 2017
1112017
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20